EBioMedicine
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
EBioMedicine
EBIOMEDICINE
ISSN / eISSN
2352-3964 / 2352-3964
Aims and Scope
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
Subject Area
MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
17.70
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology - General Biochemistry, Genetics and Molecular Biology | Q1 | #14/212 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q1 |
H-index
37
Country/Area of Publication
Netherlands
Publisher
Elsevier BV
Annual Article Volume
518
Open Access
YES
Contact
RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
Verified Reviews
2023.3.6 under review
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search